These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26028644)

  • 21. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.
    Castria D; Refini RM; Bargagli E; Mezzasalma F; Pierli C; Rottoli P
    Int J Immunopathol Pharmacol; 2012; 25(3):681-9. PubMed ID: 23058018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment.
    Bonsignore MR; Suarez Giron MC; Marrone O; Castrogiovanni A; Montserrat JM
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing complications and co-morbidities of fibrotic interstitial lung disease.
    Margaritopoulos GA; Kokosi MA; Wells AU
    Expert Rev Respir Med; 2019 Jul; 13(7):645-658. PubMed ID: 31215263
    [No Abstract]   [Full Text] [Related]  

  • 25. Idiopathic pulmonary fibrosis: phenotypes and comorbidities.
    Fell CD
    Clin Chest Med; 2012 Mar; 33(1):51-7. PubMed ID: 22365245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary on How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al.
    Ruhle KH
    Sleep Breath; 2010 Dec; 14(4):289. PubMed ID: 20232259
    [No Abstract]   [Full Text] [Related]  

  • 27. Clusters of comorbidities in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
    Respir Med; 2021; 185():106490. PubMed ID: 34130097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
    Buendía-Roldán I; Mejía M; Navarro C; Selman M
    Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?
    Mermigkis C; Bouloukaki I; Antoniou KM; Mermigkis D; Psathakis K; Giannarakis I; Varouchakis G; Siafakas N; Schiza SE
    Sleep Breath; 2013 Dec; 17(4):1137-43. PubMed ID: 23386371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis.
    Mermigkis C; Bouloukaki I; Schiza SE
    Chest; 2017 Dec; 152(6):1327-1338. PubMed ID: 28774636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue.
    Caminati A; Lonati C; Cassandro R; Elia D; Pelosi G; Torre O; Zompatori M; Uslenghi E; Harari S
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31578211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstructive sleep apnoea in acute coronary syndrome.
    Randerath W; Bonsignore MR; Herkenrath S
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31366458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep in chronic respiratory disease: COPD and hypoventilation disorders.
    McNicholas WT; Hansson D; Schiza S; Grote L
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OSA and pulmonary hypertension: time for a new look.
    Ismail K; Roberts K; Manning P; Manley C; Hill NS
    Chest; 2015 Mar; 147(3):847-861. PubMed ID: 25732450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans.
    Zieliński J
    Eur Respir J; 2005 Jan; 25(1):173-80. PubMed ID: 15640339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-operative screening for obstructive sleep apnoea.
    Verbraecken J; Hedner J; Penzel T
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep and breathing in idiopathic pulmonary fibrosis.
    Rasche K; Orth M
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():13-4. PubMed ID: 20134032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure.
    Westhoff M; Arzt M; Litterst P
    Sleep Breath; 2012 Mar; 16(1):71-8. PubMed ID: 21347650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep-related breathing disorders in idiopathic pulmonary fibrosis are frequent and may be associated with pulmonary vascular involvement.
    Hagmeyer L; Herkenrath SD; Treml M; Pietzke-Calcagnile A; Anduleit N; Randerath W
    Sleep Breath; 2023 Jun; 27(3):961-971. PubMed ID: 35922615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.